173 related articles for article (PubMed ID: 32742374)
1. CacyBP/SIP promotes tumor progression by regulating apoptosis and arresting the cell cycle in osteosarcoma.
Zhao M; Zhang RZ; Qi DW; Chen HY; Zhang GC
Exp Ther Med; 2020 Aug; 20(2):1397-1404. PubMed ID: 32742374
[TBL] [Abstract][Full Text] [Related]
2. CacyBP/SIP nuclear translocation induced by gastrin promotes gastric cancer cell proliferation.
Zhai HH; Meng J; Wang JB; Liu ZX; Li YF; Feng SS
World J Gastroenterol; 2014 Aug; 20(29):10062-70. PubMed ID: 25110433
[TBL] [Abstract][Full Text] [Related]
3. Expression and regulation of CacyBP/SIP in chronic lymphocytic leukemia cell balances of cell proliferation with apoptosis.
Fu C; Wan Y; Shi H; Gong Y; Wu Q; Yao Y; Niu M; Li Z; Xu K
J Cancer Res Clin Oncol; 2016 Apr; 142(4):741-8. PubMed ID: 26603518
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle-dependent translocation and regulatory mechanism of CacyBP/SIP in gastric cancer cells.
Chen Y; Zhang K; Wang X; Li Q; Wu Q; Ning X
Anticancer Drugs; 2018 Jan; 29(1):19-28. PubMed ID: 29099417
[TBL] [Abstract][Full Text] [Related]
5. CacyBP/SIP nuclear translocation regulates p27Kip1 stability in gastric cancer cells.
Niu YL; Li YJ; Wang JB; Lu YY; Liu ZX; Feng SS; Hu JG; Zhai HH
World J Gastroenterol; 2016 Apr; 22(15):3992-4001. PubMed ID: 27099442
[TBL] [Abstract][Full Text] [Related]
6. CacyBP/SIP protein is important for the proliferation of human glioma cells.
Shi H; Gao Y; Tang Y; Wu Y; Gong H; Du J; Zheng B; Hu J; Shi Q; Yu R
IUBMB Life; 2014 Apr; 66(4):286-91. PubMed ID: 24740456
[TBL] [Abstract][Full Text] [Related]
7. Overexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma.
Sun S; Ning X; Liu J; Liu L; Chen Y; Han S; Zhang Y; Liang J; Wu K; Fan D
Biochem Biophys Res Commun; 2007 May; 356(4):864-71. PubMed ID: 17400182
[TBL] [Abstract][Full Text] [Related]
8. CacyBP/SIP protein promotes proliferation and G1/S transition of human pancreatic cancer cells.
Chen X; Mo P; Li X; Zheng P; Zhao L; Xue Z; Ren G; Han G; Wang X; Fan D
Mol Carcinog; 2011 Oct; 50(10):804-10. PubMed ID: 21268134
[TBL] [Abstract][Full Text] [Related]
9. CacyBP/SIP inhibits Doxourbicin-induced apoptosis of glioma cells due to activation of ERK1/2.
Tang Y; Zhan W; Cao T; Tang T; Gao Y; Qiu Z; Fu C; Qian F; Yu R; Shi H
IUBMB Life; 2016 Mar; 68(3):211-9. PubMed ID: 26825673
[TBL] [Abstract][Full Text] [Related]
10. Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer.
Ning X; Sun S; Hong L; Liang J; Liu L; Han S; Liu Z; Shi Y; Li Y; Gong W; Zhang S; Chen Y; Guo X; Cheng Y; Wu K; Fan D
Mol Cancer Res; 2007 Dec; 5(12):1254-62. PubMed ID: 18171983
[TBL] [Abstract][Full Text] [Related]
11. Expression of calcyclin-binding protein/Siah-1 interacting protein in normal and malignant human tissues: an immunohistochemical survey.
Zhai H; Shi Y; Jin H; Li Y; Lu Y; Chen X; Wang J; Ding L; Wang X; Fan D
J Histochem Cytochem; 2008 Aug; 56(8):765-72. PubMed ID: 18443365
[TBL] [Abstract][Full Text] [Related]
12. CacyBP/SIP enhances multidrug resistance of pancreatic cancer cells by regulation of P-gp and Bcl-2.
Chen X; Zheng P; Xue Z; Li J; Wang W; Chen X; Xie F; Yu Z; Ouyang X
Apoptosis; 2013 Jul; 18(7):861-9. PubMed ID: 23463283
[TBL] [Abstract][Full Text] [Related]
13. Dimerization and phosphatase activity of calcyclin-binding protein/Siah-1 interacting protein: the influence of oxidative stress.
Topolska-Woś AM; Shell SM; Kilańczyk E; Szczepanowski RH; Chazin WJ; Filipek A
FASEB J; 2015 May; 29(5):1711-24. PubMed ID: 25609429
[TBL] [Abstract][Full Text] [Related]
14. S100A6 protein negatively regulates CacyBP/SIP-mediated inhibition of gastric cancer cell proliferation and tumorigenesis.
Ning X; Sun S; Zhang K; Liang J; Chuai Y; Li Y; Wang X
PLoS One; 2012; 7(1):e30185. PubMed ID: 22295074
[TBL] [Abstract][Full Text] [Related]
15. Calcyclin-binding protein/Siah-1-interacting protein as a regulator of transcriptional responses in brain cells.
Kilanczyk E; Filipek A; Hetman M
J Neurosci Res; 2015 Jan; 93(1):75-81. PubMed ID: 25163685
[TBL] [Abstract][Full Text] [Related]
16. CacyBP/SIP expression is involved in the clinical progression of breast cancer.
Wang N; Ma Q; Wang Y; Ma G; Zhai H
World J Surg; 2010 Nov; 34(11):2545-52. PubMed ID: 20585948
[TBL] [Abstract][Full Text] [Related]
17. CacyBP/SIP protein reduces p53 stability by enhancing Mdm2 activity in p53 mutant glioma cells.
Qian F; Tang T; Wang S; Wang B; Wang L; Shi H
Neoplasma; 2021 Jan; 68(1):119-125. PubMed ID: 32880469
[TBL] [Abstract][Full Text] [Related]
18. CacyBP/SIP, a calcyclin and Siah-1-interacting protein, binds EF-hand proteins of the S100 family.
Filipek A; Jastrzebska B; Nowotny M; Kuznicki J
J Biol Chem; 2002 Aug; 277(32):28848-52. PubMed ID: 12042313
[TBL] [Abstract][Full Text] [Related]
19. Newcastle Disease Virus V Protein Inhibits Cell Apoptosis and Promotes Viral Replication by Targeting CacyBP/SIP.
Chu Z; Wang C; Tang Q; Shi X; Gao X; Ma J; Lu K; Han Q; Jia Y; Wang X; Adam FEA; Liu H; Xiao S; Wang X; Yang Z
Front Cell Infect Microbiol; 2018; 8():304. PubMed ID: 30234028
[TBL] [Abstract][Full Text] [Related]
20. Expression and clinical significance of CacyBP/SIP in pancreatic cancer.
Chen X; Han G; Zhai H; Zhang F; Wang J; Li X; Huang S; Wang X; Fan D
Pancreatology; 2008; 8(4-5):470-7. PubMed ID: 18765951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
